Bajaj Healthcare surges 11% on receiving DRDO nod to manufacture 2-DG ...Middle East

The company has received a licence from DRDO to manufacture and market "2-Deoxy-D-Glucose" (2-DG) as approved medication for the treatment of COVID-19 patients

Hence then, the article about bajaj healthcare surges 11 on receiving drdo nod to manufacture 2 dg was published today ( Thursday 08/07/2021 - 08:45 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bajaj Healthcare surges 11% on receiving DRDO nod to manufacture 2-DG )

Also on site :

• Pop Star Makes Streaming History with Record-Breaking Third Album Just One Day After Release
• UK and Japan poised to seal landmark £18 billion investment deal to create thousands of jobs
• Marler Clark Urges Parents to Stop Using Nara Organics Whole Milk Organic Powdered Infant Formula Amid Multistate Infant Botulism Outbreak -- Product Sold Nationwide at Target